Search hospitals > Michigan > Kalamazoo
West Michigan Cancer Center
Claim this profileKalamazoo, Michigan 49007
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Cervical Adenocarcinoma
572 reported clinical trials
2 medical researchers
Summary
West Michigan Cancer Center is a medical facility located in Kalamazoo, Michigan. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Cervical Adenocarcinoma and other specialties. West Michigan Cancer Center is involved with conducting 572 clinical trials across 570 conditions. There are 2 research doctors associated with this hospital, such as Kathleen J. Yost and Gitonga Munene, MD.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Kathleen J. YostBronson Methodist Hospital8 years of reported clinical research
Expert in Parotid Gland Cancer
Expert in Cancer
233 reported clinical trials
343 drugs studied
Gitonga Munene, MDWest Michigan Cancer Center1 year of reported clinical research
Studies Incisional Hernias
Studies Wound Dehiscence
1 reported clinical trial
2 drugs studied
Clinical Trials running at West Michigan Cancer Center
Breast Cancer
Lung Cancer
Cancer
Parotid Gland Cancer
Breast cancer
Non-Small Cell Lung Cancer
Ovarian Cancer
Multiple Myeloma
Pancreatic Cancer
Bladder Cancer
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at West Michigan Cancer Center?
Where is West Michigan Cancer Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does West Michigan Cancer Center accept?
What awards or recognition has West Michigan Cancer Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.